Evidence map›Paper›PMID 38776887›Full record

Trial reportNeuropsychobiology2024

PROVIT-CLOCK: A Potential Influence of Probiotics and Vitamin B7 Add-On Treatment and Metabolites on Clock Gene Expression in Major Depression.

Kathrin Kreuzer, Anna Maria Birkl-Toeglhofer, Johannes Haybaeck, Alexandra Reiter, Nina Dalkner, Frederike T Fellendorf, Alexander Maget, Martina Platzer, Matthias Seidl, Lilli-Marie Mendel and 24 more

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Neuropsychobiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

34 authors.

Kathrin KreuzerClinical Department of Psychiatry and Psychotherapeutic Medicine, Medical University of Graz, Graz, Austria.
Anna Maria Birkl-ToeglhoferInstitute of Pathology, Neuropathology and Molecular Pathology, Medical University of Innsbruck, Innsbruck, Austria.
Johannes HaybaeckInstitute of Pathology, Neuropathology and Molecular Pathology, Medical University of Innsbruck, Innsbruck, Austria.
Alexandra ReiterClinical Department of Psychiatry and Psychotherapeutic Medicine, Medical University of Graz, Graz, Austria.
Nina DalknerClinical Department of Psychiatry and Psychotherapeutic Medicine, Medical University of Graz, Graz, Austria.
Frederike T FellendorfClinical Department of Psychiatry and Psychotherapeutic Medicine, Medical University of Graz, Graz, Austria.
Alexander MagetClinical Department of Psychiatry and Psychotherapeutic Medicine, Medical University of Graz, Graz, Austria.
Martina PlatzerClinical Department of Psychiatry and Psychotherapeutic Medicine, Medical University of Graz, Graz, Austria.
Matthias SeidlClinical Department of Psychiatry and Psychotherapeutic Medicine, Medical University of Graz, Graz, Austria.
Lilli-Marie MendelClinical Department of Psychiatry and Psychotherapeutic Medicine, Medical University of Graz, Graz, Austria.
Melanie LengerClinical Department of Psychiatry and Psychotherapeutic Medicine, Medical University of Graz, Graz, Austria.
Armin BirnerClinical Department of Psychiatry and Psychotherapeutic Medicine, Medical University of Graz, Graz, Austria.
Robert QueissnerClinical Department of Psychiatry and Psychotherapeutic Medicine, Medical University of Graz, Graz, Austria.
Marco MairingerClinical Department of Psychiatry and Psychotherapeutic Medicine, Medical University of Graz, Graz, Austria.
Anna ObermayerClinical Department of Psychiatry and Psychotherapeutic Medicine, Medical University of Graz, Graz, Austria.
Alexandra Kohlhammer-DohrClinical Department of Psychiatry and Psychotherapeutic Medicine, Medical University of Graz, Graz, Austria.
Tatjana Maria StrossClinical Department of Psychiatry and Psychotherapeutic Medicine, Medical University of Graz, Graz, Austria.
Alfred HäusslClinical Department of Psychiatry and Psychotherapeutic Medicine, Medical University of Graz, Graz, Austria.
Carlo HammClinical Department of Psychiatry and Psychotherapeutic Medicine, Medical University of Graz, Graz, Austria.
Helmut SchögglClinical Department of Psychiatry and Psychotherapeutic Medicine, Medical University of Graz, Graz, Austria.
Daniela Amberger-OttiClinical Department of Psychiatry and Psychotherapeutic Medicine, Medical University of Graz, Graz, Austria.
Annamaria PainoldClinical Department of Psychiatry and Psychotherapeutic Medicine, Medical University of Graz, Graz, Austria.
Theresa Lahousen-LuxenbergerClinical Department of Psychiatry and Psychotherapeutic Medicine, Medical University of Graz, Graz, Austria.
Birgitta Leitner-AfscharClinical Department of Psychiatry and Psychotherapeutic Medicine, Medical University of Graz, Graz, Austria.
Tanja FärberDiagnostic and Research Institute of Pathology, Diagnostic and Research Center of Molecular BioMedicine, Medical University of Graz, Graz, Austria.
Sabrina MörklClinical Department of Psychiatry and Psychotherapeutic Medicine, Medical University of Graz, Graz, Austria.
Jolana Wagner-SkacelClinical Department of Psychiatry and Psychotherapeutic Medicine, Medical University of Graz, Graz, Austria.
Nathalie Meier-AllardDivision of Immunology, Otto Loewi Research Center, Medical University of Graz, Graz, Austria.
Sonja LacknerDivision of Immunology, Otto Loewi Research Center, Medical University of Graz, Graz, Austria.
Sandra HolasekDivision of Immunology, Otto Loewi Research Center, Medical University of Graz, Graz, Austria.
Hansjörg HabischDivision of Medicinal Chemistry, Otto Loewi Research Center, Medical University of Graz, Graz, Austria.
Tobias MadlDivision of Medicinal Chemistry, Otto Loewi Research Center, Medical University of Graz, Graz, Austria.
Eva ReininghausClinical Department of Psychiatry and Psychotherapeutic Medicine, Medical University of Graz, Graz, Austria.
Susanne Astrid BengesserClinical Department of Psychiatry and Psychotherapeutic Medicine, Medical University of Graz, Graz, Austria.

Funding

Austrian Science Fund FWF I 3792
6 · The paper itself

Abstract

introductionAn increasing body of evidence suggests a strong relationship between gut health and mental state. Lately, a connection between butyrate-producing bacteria and sleep quality has been discussed. The PROVIT study, as a randomized, double-blind, 4-week, multispecies probiotic intervention study, aims at elucidating the potential interconnection between the gut's metabolome and the molecular clock in individuals with major depressive disorder (MDD).

methodsThe aim of the PROVIT-CLOCK study was to analyze changes in core clock gene expression during treatment with probiotic intervention versus placebo in fasting blood and the connection with the serum- and stool-metabolome in patients with MDD (n = 53). In addition to clinical assessments in the PROVIT study, metabolomics analyses with 1H nuclear magnetic resonance spectroscopy (stool and serum) and gene expression (RT-qPCR) analysis of the core clock genes ARNTL, PER3, CLOCK, TIMELESS, NR1D1 in peripheral blood mononuclear cells of fasting blood were performed.

resultsThe gene expression levels of the clock gene CLOCK were significantly altered only in individuals receiving probiotic add-on treatment. TIMELESS and ARNTL gene expression changed significantly over the 4-week intervention period in both groups. Various positive and negative correlations between metabolites in serum/stool and core clock gene expression levels were observed.

conclusionChanging the gut microbiome by probiotic treatment potentially influences CLOCK gene expression. The preliminary results of the PROVIT-CLOCK study indicate a possible interconnection between the gut microbiome and circadian rhythm potentially orchestrated by metabolites.

Indexed as

CLOCK ProteinsMajor Depressive DisorderProbioticsAdultDouble-Blind MethodFecesFemaleGastrointestinal MicrobiomeGene ExpressionHumansMaleMetabolomeMiddle AgedCLOCK protein, humanCLOCK ProteinsCircadian clock genesGut-brain axisMajor depressive disorderRandomized controlled trial

Identifiers

PMID38776887
PMCPMC11548105

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.